Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ARCOMA.STthis companyArcoma AB	SEK 8.50	20.97×	1.41×	0.8×	4.36×	-14.6%	5.2%	6.6%	3.8%	6.7%	9.3%	12.5%	0×	-2.2×	73.58×	3.49×	0.0%	6	6.68	3	B+
BIOSGN.STBiosergen AB	SEK 0.49	-20.76×	72.03×	0×	-20.37×	34.2%	0.0%	0.0%	0.0%	-347.0%	-351.9%	-4.3%	0×	0.38×	-4,139.3×	2.46×	0.0%	2	-8.67	—	—
BIOVIC-B.STBiovica International AB (publ)	SEK 0.32	-1.17×	0.95×	6.14×	-0.26×	-1052.3%	-523.5%	-523.5%	-522.1%	-80.9%	-76.5%	-77.0%	0.05×	1.07×	-176.89×	4.3×	0.0%	3	-9.24	2	C
BRAIN.STBrainCool AB (publ)	SEK 1.06	-3.95×	0.85×	4.14×	-3.68×	-1142.9%	-112.9%	-95.1%	-102.3%	-21.1%	-18.8%	-37.7%	0×	1.32×	-8.86×	7.03×	0.0%	2	22.35	1	C-
ICO.STIconovo AB (publ)	SEK 1.10	-1×	0.37×	39.24×	-1.23×	-96.0%	-3959.5%	-3959.5%	-3924.3%	-36.8%	-36.0%	-106.0%	0.04×	0.05×	-97.45×	1.01×	0.0%	4	4.35	2	C+
LXB.STLuxbright AB (publ)	SEK 6.50	-2.9×	2.09×	4.94×	-3.32×	-5295.1%	-187.2%	-187.2%	-170.5%	-72.4%	-67.9%	-35.3%	0.17×	0.04×	-54.72×	1.38×	0.0%	2	-1.35	2	C+
Peer median	—	-2.9×	0.95×	4.94×	-3.32×	-1052.3%	-187.2%	-187.2%	-170.5%	-72.4%	-67.9%	-37.7%	0.04×	0.38×	-97.45×	2.46×	0.0%	2	-1.35	2	—